NWBO Northwest Biotherapeutics, Inc. $NWBO Company Overview

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
NWBO Northwest Biotherapeutics, Inc. $NWBO Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=NWBO&...mp;yt0=Go!

Last Updated: 06/03/2016 22:34:10

Current Price and Quotes
Last Price 0.7844
Previous Close 0.75 Open 0.76
Daily Range 0.74 - 0.7899 52wk Range 0.74 - 12.55
Volume 1,493,383 Dividend N/A
Average Vol (30d) 625,896 Net Dividend Yield N/A




Financials
Period Ending Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012
Total Revenue 1,739 1,454 809 772
Cost of Revenue - - - -
Gross Profit 1,739 1,454 809 772
Operating Expenses

Research and Development 103,120 85,637 43,906 28,908
Sales, General and Admin. 24,903 16,960 12,377 15,675
Non-Recurring Items - - - -
Other - - - 14
Operating Income (126,284) (101,143) (55,474) (43,825)
Income From Continuing Operations

Add'l Income/Expense Items 15,696 (33,495) (9,473) (10,053)
Earnings Before Interest and Tax (110,588) (134,638) (64,947) (53,878)
Interest Expense 4,153 996 842 13,442
Earnings Before Tax (114,741) (135,634) (65,789) (67,320)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (114,741) (135,634) (65,789) (67,320)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (114,741) (135,634) (65,789) (67,320)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (114,741) (135,634) (65,789) (67,320)

Recent News
Source
May 16, 2016 Northwest Bio makes a sweet deal for warrant holders; shares down 9% Seeking Alpha
May 2, 2016 NW Bio Announces Operations Updates PR NEWSWIRE
Jan 25, 2016 Northwest Bio appoints two independent directors Seeking Alpha
Jan 8, 2016 Northwest Bio says the market the villain behind recent share price softness Seeking Alpha
Dec 24, 2015 Premarket Biotech Digest: Gilead's M&A Focus, MannKind Appoints CEO, Northwest Tumbles Seeking Alpha
Dec 23, 2015 Northwest Bio down 16% premarket on discounted direct equity offering Seeking Alpha
Dec 22, 2015 Northwest Bio: The Accusations Fly Seeking Alpha
Dec 9, 2015 Premarket Biotech Digest: Relypsa Undervalued, Northwest Forms Committee, Oncothyreon Tumbles Seeking Alpha
Dec 8, 2015 Northwest Bio forms Special Committee to investigate alleged questionable financial dealings by CEO Powers Seeking Alpha
Nov 17, 2015 Premarket Biotech Digest: Isis' Potential, Clovis Sell-Off, Arrowhead Data Seeking Alpha

1
2
3
4
next >

NWBO Northwest Biotherapeutics, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=NWBO&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NWBO/quote
Stock Chart http://www.otcmarkets.com/stock/NWBO/chart
Company Info http://www.otcmarkets.com/stock/NWBO/company-info
Recent News http://www.otcmarkets.com/stock/NWBO/news
Financials http://www.otcmarkets.com/stock/NWBO/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NWBO/filings
Short Sales http://www.otcmarkets.com/stock/NWBO/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NWBO/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NWBO/research
Summary http://finance.yahoo.com/q?s=NWBO
Historical Prices http://finance.yahoo.com/q/hp?s=NWBO+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NWBO
Basic Chart http://finance.yahoo.com/q/bc?s=NWBO+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NWBO+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NWBO+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NWBO+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NWBO+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NWBO+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NWBO+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NWBO+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NWBO+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NWBO+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NWBO
Balance Sheet http://finance.yahoo.com/q/bs?s=NWBO
Cash Flow http://finance.yahoo.com/q/cf?s=NWBO+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NWBO
Market Watch http://www.marketwatch.com/investing/stock/NWBO
Bloomberg http://www.bloomberg.com/quote/NWBO:US
Morningstar http://quotes.morningstar.com/stock/s?t=NWBO
Bussinessweek http://investing.businessweek.com/research/st...icker=NWBO
Barchart http://www.barchart.com/quotes/stocks/NWBO
OTC Short Report http://otcshortreport.com/index.php?index=NWBO
Investopedia http://www.investopedia.com/markets/stocks/NWBO/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading